AngelEye Health, Inc. — SEC Form D Filing

AngelEye Health, Inc. filed an SEC Form D on September 24, 2026, reporting $10.00M raised in Health Technology.

Form D filing details

Filing
SEC Form D
Filing date
September 24, 2026
Amount reported
$10.00M
Round stage
Series B+
Industry
Health Technology
Website
https://www.angeleyehealth.com/

What the company does

Securities: Equity. Exemption: Rule 506(b). Incorporated: DELAWARE

Problem

Neonatal Intensive Care Units (NICUs) face challenges in caring for medically fragile infants, supporting families, and preventing readmissions, often due to parents forgetting care instructions after discharge. This can lead to inefficiencies for clinical teams and adverse outcomes for infants.

Solution

AngelEye Health provides an integrated platform with solutions for NICU navigation, discharge coordination, feeding management, and live-stream video with messaging. This platform aims to improve communication, education, and clinical workflows, ultimately enhancing family experience and health outcomes for hospitalized infants.

Why now

The increasing demand for family-integrated care, the need for improved communication in healthcare settings, and the adoption of digital health solutions in hospitals (especially NICUs) are driving the relevance of AngelEye's offerings.

Verdict

Investors said yes to AngelEye Health's Series B+ because it offered a clear product-market fit for an underserved, high-stakes hospital unit, not because it was pioneering a new category of health technology. They implicitly bet on the narrative of workflow optimization and patient engagement within a specialized department, where efficiency gains and improved outcomes offered measurable ROI for hospital systems. This limited upside to capturing a niche, rather than scaling across broader hospital operations or establishing a de-facto standard.

Source: SEC EDGAR Form D filing